What is the recommended rate of In Vitro Fertilization (IVF) for a patient with Chronic Kidney Disease (CKD) stage IV and Acute Kidney Injury (AKI) with impaired renal function, specifically a glomerular filtration rate (GFR) of 15?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a patient with CKD stage IV who has developed an AKI with a GFR of 15 mL/min, I would recommend starting intravenous fluids (IVF) at a very conservative rate of 30-50 mL/hour using isotonic crystalloids such as normal saline or lactated Ringer's solution. This patient has severely compromised renal function and is at high risk for volume overload, which could worsen their condition. According to the guidelines outlined in 1, a GFR of 15 mL/min falls under stage 5 CKD, indicating severe kidney dysfunction. Close monitoring is essential, including:

  • Hourly urine output
  • Daily weights
  • Intake and output measurements
  • Frequent reassessment of vital signs and physical exam for signs of fluid overload (crackles on lung exam, peripheral edema, jugular venous distention) Laboratory values including BUN, creatinine, and electrolytes should be checked at least daily, as suggested by the CKD guidelines in 1. The IVF rate should be adjusted based on the patient's clinical response, with consideration for reducing or discontinuing fluids if signs of volume overload develop. The rationale for this conservative approach is that patients with severe kidney dysfunction have limited ability to excrete excess fluid and electrolytes, and aggressive fluid administration could precipitate pulmonary edema, hypertension, and heart failure. Nephrology consultation should be obtained immediately, as this patient may require renal replacement therapy depending on their clinical course and the underlying cause of the AKI.

From the Research

IVF Rate for Patients with CKD IV and AKI

  • The provided studies do not directly address the optimal rate of IVF for patients with CKD IV and AKI with a GFR of 15 2, 3, 4, 5, 6.
  • However, the studies discuss the relationship between kidney disease, preeclampsia, and hypertensive disorders in pregnancy, which may be relevant for patients with CKD IV and AKI 2, 3, 5, 6.
  • A study on chronic kidney disease diagnosis and management suggests that patients with CKD require careful monitoring and management to prevent adverse outcomes, including cardiovascular disease and end-stage kidney disease 4.
  • Another study on hypertensive diseases in pregnancy and kidney function later in life found that women with a history of hypertensive pregnancy had lower kidney function and higher odds of chronic kidney disease compared to women with a history of normotensive pregnancies 5.
  • The complex relationship between preeclampsia and kidney disease is also discussed, with evidence suggesting that preeclampsia may be an important sex-specific risk factor for chronic kidney disease 6.

Considerations for IVF in Patients with CKD IV and AKI

  • Patients with CKD IV and AKI may require individualized care and monitoring due to their increased risk of adverse outcomes 4, 5, 6.
  • The decision to start IVF in these patients should be made on a case-by-case basis, taking into account their overall health, kidney function, and potential risks and benefits of IVF 2, 3, 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Preeclampsia and Long-term Kidney Outcomes: An Observational Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2023

Research

Preeclampsia and Kidney Disease: Deciphering Cause and Effect.

Current hypertension reports, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.